Easy Bio Inc
KOSDAQ:353810
Balance Sheet
Balance Sheet Decomposition
Easy Bio Inc
Easy Bio Inc
Balance Sheet
Easy Bio Inc
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
20 447
|
20 703
|
39 911
|
29 068
|
59 856
|
|
| Cash |
0
|
563
|
464
|
1 709
|
1 568
|
|
| Cash Equivalents |
20 447
|
20 140
|
39 447
|
27 359
|
58 288
|
|
| Short-Term Investments |
1 490
|
850
|
1 216
|
737
|
823
|
|
| Total Receivables |
18 543
|
18 058
|
35 232
|
61 145
|
99 966
|
|
| Accounts Receivables |
18 265
|
16 258
|
21 149
|
21 811
|
41 721
|
|
| Other Receivables |
278
|
1 800
|
14 083
|
39 335
|
58 245
|
|
| Inventory |
16 445
|
23 925
|
28 808
|
25 939
|
53 554
|
|
| Other Current Assets |
1 336
|
1 724
|
2 159
|
2 682
|
4 828
|
|
| Total Current Assets |
58 262
|
65 259
|
107 327
|
119 571
|
219 027
|
|
| PP&E Net |
30 562
|
36 080
|
34 861
|
34 393
|
64 558
|
|
| PP&E Gross |
30 562
|
36 080
|
34 861
|
34 393
|
64 558
|
|
| Accumulated Depreciation |
24 921
|
30 743
|
33 950
|
36 932
|
56 474
|
|
| Intangible Assets |
110
|
2 150
|
1 903
|
1 811
|
22 318
|
|
| Goodwill |
0
|
4 647
|
4 647
|
5 101
|
43 746
|
|
| Note Receivable |
90
|
1 381
|
695
|
547
|
1 157
|
|
| Long-Term Investments |
424
|
6 550
|
6 663
|
7 607
|
8 362
|
|
| Other Long-Term Assets |
374
|
1 627
|
1 714
|
3 012
|
843
|
|
| Other Assets |
0
|
4 647
|
4 647
|
5 101
|
43 746
|
|
| Total Assets |
89 822
N/A
|
117 694
+31%
|
157 810
+34%
|
172 042
+9%
|
360 012
+109%
|
|
| Liabilities | ||||||
| Accounts Payable |
8 107
|
8 624
|
10 550
|
10 560
|
30 793
|
|
| Accrued Liabilities |
244
|
444
|
769
|
1 146
|
2 570
|
|
| Short-Term Debt |
19 168
|
30 635
|
61 820
|
46 278
|
57 130
|
|
| Current Portion of Long-Term Debt |
1 513
|
15 692
|
3 220
|
5 546
|
15 068
|
|
| Other Current Liabilities |
6 865
|
8 213
|
8 708
|
8 388
|
22 197
|
|
| Total Current Liabilities |
35 897
|
63 609
|
85 067
|
71 919
|
127 758
|
|
| Long-Term Debt |
16 558
|
4 891
|
17 193
|
30 454
|
137 431
|
|
| Deferred Income Tax |
461
|
1 182
|
946
|
638
|
3 123
|
|
| Minority Interest |
0
|
2 496
|
2 848
|
3 391
|
4 828
|
|
| Other Liabilities |
2 866
|
2 597
|
1 793
|
2 858
|
2 901
|
|
| Total Liabilities |
55 782
N/A
|
74 776
+34%
|
107 847
+44%
|
109 260
+1%
|
276 041
+153%
|
|
| Equity | ||||||
| Common Stock |
3 419
|
3 419
|
3 419
|
3 419
|
3 419
|
|
| Retained Earnings |
10 430
|
19 085
|
26 238
|
38 575
|
61 339
|
|
| Additional Paid In Capital |
20 357
|
21 984
|
21 423
|
21 478
|
14 478
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
7 566
|
|
| Treasury Stock |
166
|
166
|
166
|
166
|
4 157
|
|
| Other Equity |
0
|
1 404
|
951
|
524
|
1 326
|
|
| Total Equity |
34 040
N/A
|
42 918
+26%
|
49 963
+16%
|
62 782
+26%
|
83 971
+34%
|
|
| Total Liabilities & Equity |
89 822
N/A
|
117 694
+31%
|
157 810
+34%
|
172 042
+9%
|
360 012
+109%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
34
|
34
|
34
|
34
|
33
|
|